ITV Extension Study

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

September 30, 2002

Study Completion Date

September 30, 2003

Conditions
HIV
Interventions
BIOLOGICAL

recombinant fowlpoxvirus (rFPV) expressing HIV gag-pol antigens

BIOLOGICAL

HIV gag-pol antigens and interferon-gamma (IFN-y)

Trial Locations (6)

2010

407 Doctors, Sydney

Ground Zero Medical Practice, Sydney

Holdsworth House Medical Practice, Sydney

St Vincents Hospital, Sydney

3004

The Alfred Hospital, Melbourne

3053

Carlton Clinic, Melbourne

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

The University of New South Wales

OTHER

collaborator

Virax Pty. Ltd,

INDUSTRY

lead

Kirby Institute

OTHER_GOV

NCT00332930 - ITV Extension Study | Biotech Hunter | Biotech Hunter